Hemoglobin A1c Monitoring Market - Global Strategic Business Report 2016 - Increasing Diabetes Prevalence & Need for Diabetes Management to Prop-up Demand for HbA1c Testing Devices - Research and Markets

News provided by

Jun 28, 2016, 02:10 ET

DUBLIN, June 28, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Hemoglobin A1c Monitoring - Global Strategic Business Report" report to their offering.

The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for Hemoglobin A1c Monitoring in US$ by the following Test Types: HbA1c Laboratory Testing, and HbA1c Point of Care Testing.

The report profiles 25 companies including many key and niche players such as

Abbott Laboratories (US)
Alere, Inc. (US)
ARKRAY, Inc. (Japan)
Beckman Coulter, Inc. (US)
Bio-Rad Laboratories, Inc. (US)
Diazyme Laboratories Inc. (US)
EKF Diagnostics Holdings Plc (UK)
HemoCue® AB (Sweden)
Infopia Co., Ltd. (South Korea)
A.Menarini Diagnostics Ltd. (UK)
PTS Diagnostics (US)
Roche Diagnostics (Switzerland)
Siemens Healthineers (Germany)
Tosoh Bioscience, Inc. (US)
Trinity Biotech plc (Ireland)

Key Topics Covered:

1. MARKET OVERVIEW

HbA1c Devices: Critical Role in Monitoring & Management of Diabetes
Growth Stimulants in a Nutshell
Major Concerns
POC-based HbA1c Testing Challenges the Dominance of Laboratory-based HbA1c Testing Market
Increasing Diabetes Prevalence & Need for Diabetes Management to Prop-up Demand for HbA1c Testing Devices
High Risk of Diabetes in Aging Demographics Promises Growth in HbA1c Testing Devices Market
Increasing Obesity Levels Underpins Market Growth
Developing Nations: Growth Opportunities Abound for HbA1c Testing Market
Manufacturers Focus on Offering Products for Developing Markets
Increasing Healthcare Expenditure Aids Diabetes Diagnostics & Testing Market
Approval for HbA1c Testing for Diabetes Diagnosis: An Opportunity to Tap
Is HbA1c Test Right in Being Recommended for Diagnostic Purposes?
Technology Developments Transform Diagnostics in Diabetes Care
HbA1c Tests for Diabetes Diagnosis
Need to Address Issues Related to Hemoglobin Variants
Efforts Focus on Standardization Reporting of HbA1c Results
Consistent and Precise Test Results Favor Growth in the HbA1c Testing Devices Market
Glycosylated Hemoglobin Tests Pave the Way for Early-Stage Diabetes Diagnosis
Near Patient Testing Gaining Ground
Despite Reliability Issues, Prospects Remain Positive for POC Testing Market
Advantages of POC HbA1c Tests over Lab Tests to Foster Adoption
Major Testing Methods in POC HbA1c Tests
Immunoassays
Boronate Affinity Chromatography
Micro-Optical Detection Methods
Select HbA1c POC Tests in the Market
A Comparison
Home HbA1c Testing
Lack of Reimbursement Coverage & Accuracy Concerns Affect Adoption
Regular HbA1c Test Keeps Heart Risk at Bay
Glycated Albumin
A Potential Threat to HbA1c?
Higher Levels of Glycosylated Hemoglobin Increases Risk of Death
Non-Invasive Glucose Meters and CBGM Devices Threaten HbA1c Market
ESC and ADA Release Revised Guidelines for HbA1c Testing
Study Finds Dentist Visits to be an Opportunity for HbA1c- based Diabetes Screening & Management
Competitive Landscape
Select Laboratory-based HbA1c Testing Products/Analyzers
Select Point of Care HbA1c Testing Products/Analyzers

2. DIABETES - A BRIEF PROFILE OF THE DISEASE

What Causes Diabetes?
Types of Diabetes
Major Types of Diabetes
Likely Complications
Nephropathy (Kidney Disease)
Diabetic Neuropathy (Nerve Damage)
Retinopathy (Damage to the Eye and Blindness)
Poor Healing of Infections and Wounds
Impotence in Men
Periodontal Disease
Cardiovascular Disease
Interpreting the A1c Range
Blood Glucose Level Guidelines in the US
A Glance at Key Diabetes Statistics
Therapeutic Options for Diabetes
Oral Medications for Type 2 Diabetes
Side Effects of Insulin Therapy
Maintaining A1c Test Result Below 7%
Common Diabetes Management Practices

3. PRODUCT OVERVIEW

Hemoglobin
A Brief
Hemoglobin A1c- Description
HbA1c Monitoring
What is A1c?
1. HbA1c Laboratory Testing
2. HbA1c Point of Care Testing & Self-Monitoring
Hemoglobin A1c (HbA1c) Test
Interpreting HbA1c Test Readings
Interpreting HbA1c Test Readings
Result of Hemoglobin A1c Test
Clinical Use of A1c Testing
Advantages of A1c Assessment & Interpretation
Risks Associated with HbA1c Testing
Methods of Measurement for Glycohemoglobin
Why Opt for HbA1c Testing?
The Diabetes Control & Complications Trial (DCCT)
The Kumamoto and UK Prospective Studies
Glycemia Tests Used in Monitoring Diabetes
Urine Glucose Testing
Glycated Protein Testing
Table 22: Relation Between A1c Level and Mean Plasma Glucose Levels
HbA1c Test Types
HbA1c Laboratory Testing
Analytical Techniques Used for Quantifying HbA1c in Labs
Standardization of HbA1c Results
Table 23: CAP Accuracy Grading for HbA1c Measurements (2007-2013)
HbA1c Point of Care Testing & Self-Monitoring
Standardization of Glycated Hemoglobin Testing
NGSP Standardization of HbA1c
IFCC Standardization of HbA1c
HbA1c Reporting

4. PRODUCT INNOVATIONS/INTRODUCTIONS

ARKRAY Unveils New Instruments for HbA1c Measurement
Roche Introduces New Cobas C513 Analyser
ARKRAY Launches B-analyst HbA1c Control for HbA1c Tests
ARKRAY Unveils CinQ HbA1c Range of Reagent Kit
Transasia Bio-Medicals Introduces HbA1c & HbA2/F-Fully Automated Analyzer
ARKRAY Releases PocketChem A1c HbA1c Analyzer
Beckman Coulter Introduces Next-Generation Hemoglobin A1c
ARKRAY Unveils ADAMS A1c mini Glycated-Hemoglobin Analyzer
Axis-Shield Introduces HbA1c Turbidimetric Immunoassay
Abbott Introduces New A1c Test for Diabetes Diagnosis
Sanofi Introduces Self-Monitoring Device Offering HbA1c Values
ARKRAY Unveils ADAMS Hybrid AH-8290 Dual HbA1c and Glucose Analyzer
ARKRAY Releases ADAMS A1c HA-8180V and ADAMS A1c HA-8180T Analyzers
Sebia Unveils Capillarys HbA1c Assay

5. RECENT INDUSTRY ACTIVITY

Siemens Healthcare Rebrands as Siemens Healthineers
Sinocare to Acquire PTS Diagnostics
Abbott Inks Definitive Agreement to Takeover Alere
Bio-Rad Bags FDA Approval for D-100 System for A1c Testing
Bio-Rad's VARIANT II TURBO HbA1c Kit
2.0 Receives FDA Approval for Use in Diabetes Diagnosis
Abnova Concludes Clinical Trial for Personal A1c Diabetes Rapid Test
Ortho-Clinical Diagnostics Obtains FDA Approval for VITROS® Chemistry Products HbA1c Reagent Kit
Abbott Gains FDA Approval for ARCHITECT Clinical Chemistry HbA1c Test
PTS Acquires Bayer's A1CNow® Product Family
Radiometer Acquires HemoCue
BioHermes Acquires HbA1c Technology from Scripps Laboratories